growth hormone-releasing factor

(redirected from Growth hormone releasing hormone)
Also found in: Dictionary, Medical, Wikipedia.
Related to Growth hormone releasing hormone: somatostatin, Gonadotropin releasing hormone
  • noun

Synonyms for growth hormone-releasing factor

a releasing factor that accelerates the secretion of growth hormone by the anterior pituitary body

References in periodicals archive ?
Growth Hormone Releasing Peptides and Growth Hormone Releasing Hormones offer legal, safe, inexpensive and effective benefits
MEN-1: Multiple endocrine neoplasia type 1, NECT: Neuroendocrine tumor, GHRH: Growth hormone releasing hormone, GH: Growth hormone, IGF-1: Insulin like growth factor.
Improved expression of muscle-derived growth hormone releasing hormone from [alpha]-skeletal-muscle actin enhancer/cytomegalovirus.
1), (2) These central nervous system (CNS) controls result in the elaboration of growth hormone releasing hormones (GHRH), which act on the anterior pituitary to release GH.
Doug Kern, VP, Business Development of VGX Animal Health, stated, "This is the first time a single dose of a plasmid-based growth hormone releasing hormone therapy has been directly compared to daily injections of growth hormone.
Vitalife is the world's first and only transdermal growth hormone releasing hormone (GHRH) analog.
VGX Pharmaceuticals plans to file three INDs for its SynCon[TM] DNA-based product candidates during the first two quarters of 2008: VGX-3100, a therapeutic vaccine for the treatment for cervical cancer; VGX-3200, a therapeutic based on human growth hormone releasing hormone for cancer-related cachexia (wasting or heavy weight loss); and VGX-3400, a pandemic avian flu vaccine.
VGXAH), a developer of cutting edge technologies for animal health applications, announced today the approval by the Australian Pesticides and Veterinary Medicines Authority (APVMA) of LifeTide[TM] SW 5, the Company's leading Growth Hormone Releasing Hormone (GHRH) product for swine therapy.
TSX: LAB), a fully-integrated drug development company focused on the inhalation market, today announced positive results from the phase I/II trial for its proprietary 29 amino-acid peptide analogue of Growth Hormone Releasing Hormone (GHRH).
VGX Pharmaceuticals plans to file three additional INDs for its SynCon[TM] DNA vaccine candidates during the first two quarters of 2008: VGX-3100, a therapeutic vaccine for the treatment for cervical cancer; VGX-3200, a therapeutic based on human growth hormone releasing hormone (GHRH) for cancer-related cachexia (wasting or heavy weight loss); and VGX-3400, a pandemic avian flu vaccine.
Most of these children retain response to growth hormone releasing hormone.
VGX is currently developing a portfolio of DNA based vaccines covering HIV, HPV and influenza as well as DNA therapies for cancer-related cachexia based on growth hormone releasing hormone (GHRH).
Serono has developed and markets the most comprehensive line of products to treat pediatric growth hormone deficiency, including growth hormone and growth hormone releasing hormone.
The candidates include vaccines for human papilloma virus for the treatment of cervical cancer (VGX-3100) and avian influenza (VGX-3400), and a therapeutic based on human growth hormone releasing hormone (VGX-3200) for cancer related cachexia.
Full browser ?